Stuart Taylor

Stuart Taylor is a seasoned analytical chemist currently serving as a Senior Scientist at Purespring Therapeutics since July 2024, focusing on AAV HPLC method development, validation, and transfer. Prior experience includes roles at Novartis and Gyroscope Therapeutics, where Stuart expanded expertise in downstream process development and independently developed HPLC methods for AAV gene therapy vectors. Previous positions at GSK and RB involved method development, validation, and regulatory submissions, highlighting proficiency in project management and technical communication. Stuart’s career began with internships at Symrise, and academic credentials include a Bachelor of Science in Chemistry from The University of Sheffield. Stuart is recognized for strong data analysis skills and an ability to work collaboratively in high-pressure environments.